Anterior Referencing Versus Posterior Referencing in Minimally Invasive Total Knee Arthroplasty

NCT ID: NCT01135030

Last Updated: 2012-02-06

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 100 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2006-10-31
• Study Completion Date: 2012-01-31

Brief Summary

The purpose of this study is to look at two different referencing systems for total knee replacement surgery. In anterior referencing system, referencing cuts are made from the front surface of the femur. This allows for a more exact cut. The anterior referencing system is more difficult for the surgeon to use. This may increase surgery time. Posterior referencing, on the other hand, references cuts from the back of the femur. The posterior referencing system is quick and easy for the surgeon to use. Posterior referencing may lead to notching of the femur. The risk of notching is very low and may not affect your results. This is a study that has never been done before. Dr. Heekin uses both referencing systems in his practice. He would like to determine which knee referencing system allows for greater knee flexion after surgery. Knee flexion correlates with function and the ability to return to everyday activities. For example, getting up from a chair, going up and down stairs, stooping, and kneeling.

Conditions

Osteoarthritis

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Posterior referencing

Group Type: ACTIVE_COMPARATOR

Total knee

Intervention Type: PROCEDURE

Primary Total knee

Anterior referencing

Group Type: ACTIVE_COMPARATOR

Total knee

Intervention Type: PROCEDURE

Primary Total knee

Interventions

Total knee

Primary Total knee

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

1. Patient is a male or non-pregnant female between the ages of 21-80.

2. Patient requires cemented primary total knee replacement.

3. Patient has a diagnosis of osteoarthritis (OA), traumatic arthritis (TA), or avascular necrosis (AVN).

4. Patient has intact collateral ligaments.

5. Patient has signed and dated an IRB approved study specific consent form.

6. Patient is able and willing to participate in the study according to the protocol for the full length of expected term of follow-up, and to follow their physician's directions.

7. Patient has failed to respond to conservative treatment modalities.

8. Patient's contralateral knee is without symptomatic degenerative disease.

Exclusion Criteria

1. Patient has had a prior procedure of high tibial osteotomy, cruciate ligament reconstruction or patellectomy of the surgical knee.

2. Patient is morbidly obese (BMI >30).

3. Patient has a deformity at the involved knee greater than 45degrees of flexion, 45 degrees of varus or 45 degrees of valgus.

4. Patient has an active or suspected latent infection in or about the knee joint.

5. Patient has a malignancy in the area of the involved knee joint.

6. Patient has a diagnosed systematic disease that would affect the subject's welfare or overall outcome of the study (i.e. moderate to severe osteoporosis, Paget's disease, renal osteodystrophy) or is immunologically suppressed, or receiving steroids in excess of physiologic dose requirements.

7. Patient has a neurological deficit, which interferes with the patient's ability to limit weight bearing or places an extreme load on implant during the healing period.

8. Female patient is or plans to become pregnant during the course of the study.

9. Patient has a known sensitivity to device materials.

10. Patient has prior diagnosis of diabetic or peripheral neuropathy in operative extremity or other neurologic disease affecting limb strength (i.e. Polymyositis, multiple sclerosis).

11. Patient's bone stock is compromised by disease or infection, which cannot provide adequate support and/or fixation to the prosthesis.

12. Patient has a TKA on the contralateral side less than six months post-op.

13. Patient has participated in an orthopaedic clinical investigation involving the hip or knee joint in the last 12 months.

• Minimum Eligible Age: 21 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Stryker Orthopaedics

INDUSTRY

Sponsor Role: collaborator

Heekin Orthopedic Research Institute

OTHER

Sponsor Role: lead

Responsible Party

R. David Heekin

R. David Heekin, M.D.

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Heekin Orthopedic Specialists

Jacksonville, Florida, United States

Countries

United States

Other Identifiers

06-09-03

Identifier Type: -

Identifier Source: org_study_id